GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
W

WELL Health Technologies WELL.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

4.25

+2.16%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Popular Bitcoin Ethereum Nvidia Apple S&P 500 Gold EUR/USD US 10Y

At a glance

Figures in CAD, from our data supplier.

FY2025

Revenue

C$1.40bn

FY2016FY2025

Net income

−C$50.2m

FY2016FY2025

Free cash flow

C$87.9m

FY2016FY2025

Shareholders' equity

C$863.5m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueC$1.40bnC$919.7mC$776.1mC$569.1mC$302.3mC$50.2mC$32.8mC$5.9mC$414,856C$284,621
Gross profitC$525.1mC$363.0mC$372.3mC$303.3mC$153.7mC$21.2mC$11.0mC$1.7mC$128,303C$48,216
Research and development——C$3.5mC$3.2m——————
Operating incomeC$61.5mC$44.6mC$35.2mC$23.3m−C$6.2m−C$9.9m−C$6.3m−C$2.0m−C$905,913−C$979,258
Net income−C$50.2mC$32.6mC$82,000C$19.1m−C$30.7m−C$2.6m−C$7.8m−C$2.0m−C$10.2m−C$585,396
Diluted earnings per share-0.330.130.000.08-0.15-0.02-0.07-0.03-0.25-0.05

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsC$2.10bnC$1.81bnC$1.41bnC$1.32bnC$1.26bnC$262.7mC$58.5mC$12.8mC$442,223C$948,143
Cash and short-term investmentsC$133.8mC$131.7mC$43.4mC$48.9mC$61.9mC$86.9mC$15.6mC$2.5mC$266,474C$36,958
Total liabilitiesC$1.06bnC$877.6mC$563.2mC$503.8mC$554.4mC$43.8mC$26.5mC$2.6mC$1.1mC$474,976
DebtC$714.1mC$473.1mC$426.3mC$358.4mC$401.9mC$23.6mC$19.2m—C$702,005C$61,482
Shareholders' equityC$863.5mC$867.6mC$767.7mC$732.3mC$618.2mC$217.4mC$32.0mC$10.1m−C$661,785C$473,167
Shares outstanding151m249m240m230m210m163m118m81m41m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsC$115.8mC$9.5mC$66.4mC$76.5mC$22.3m−C$5.4m−C$2.6m−C$1.2m−C$884,207−C$448,403
Capital spending−C$27.9m−C$16.2m−C$25.4m−C$6.4m−C$2.7m−C$1.1m−C$472,413−C$83,706——
Free cash flowC$87.9m−C$6.7mC$41.1mC$70.1mC$19.6m−C$6.5m−C$3.1m−C$1.3m−C$884,207−C$448,403

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueC$400.4mC$368.3mC$384.8mC$364.6mC$356.7mC$294.1mC$193.2mC$251.7m
Gross profitC$178.4mC$137.6mC$109.6mC$139.3mC$158.7mC$117.5mC$41.2mC$112.3m
Operating incomeC$22.8mC$19.8mC$39.2mC$22.8mC$27.1mC$7.6m−C$63.9mC$15.0m
Net income−C$10.9m−C$12.4mC$22.9mC$4.2mC$12.2m−C$46.6m−C$13.0m−C$81.2m
Diluted earnings per share-0.04-0.050.150.030.08-0.31-0.05-0.33
Cash from operationsC$39.0mC$14.0mC$42.0mC$27.0mC$27.0mC$21.0m−C$102.0mC$57.0m
Capital spending−C$12.0m−C$10.0m−C$8.0m−C$8.0m−C$5.0m−C$5.0m−C$5.0m−C$3.0m
Free cash flowC$27.0mC$4.0mC$34.0mC$19.0mC$22.0mC$16.0m−C$107.0mC$54.0m
Total assetsC$2.38bnC$2.17bnC$2.10bnC$2.02bnC$2.02bnC$1.81bnC$1.81bnC$1.59bn
Cash and short-term investmentsC$130.6mC$134.0mC$133.8mC$82.5mC$98.9mC$103.2mC$131.7mC$66.2m
DebtC$751.8mC$725.7mC$733.8mC$624.1mC$621.5mC$524.1mC$473.1mC$396.4m
Shareholders' equityC$827.8mC$867.8mC$863.5mC$844.4mC$826.2mC$834.4mC$867.6mC$847.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue35.0%94.5%125.6%
Operating income38.2%——
Net income—80.5%79.3%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin38.3%42.7%43.3%43.2%
Operating margin4.6%4.5%3.7%3.4%
Net margin-0.8%0.0%-0.8%-1.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings-12.052.4—34.2-33.6-500.4-23.6-17.8-1.8-3.0
Price to sales0.41.91.21.13.426.15.66.243.86.1

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.